FI972054A0 - Immunogeenisiä koostumuksia - Google Patents

Immunogeenisiä koostumuksia

Info

Publication number
FI972054A0
FI972054A0 FI972054A FI972054A FI972054A0 FI 972054 A0 FI972054 A0 FI 972054A0 FI 972054 A FI972054 A FI 972054A FI 972054 A FI972054 A FI 972054A FI 972054 A0 FI972054 A0 FI 972054A0
Authority
FI
Finland
Prior art keywords
immunogenic compositions
immunogenic composition
solubilised
immunogen
absence
Prior art date
Application number
FI972054A
Other languages
English (en)
Swedish (sv)
Other versions
FI972054A (fi
Inventor
Roger Randal Charles New
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of FI972054A publication Critical patent/FI972054A/fi
Publication of FI972054A0 publication Critical patent/FI972054A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
FI972054A 1994-11-15 1997-05-14 Immunogeenisiä koostumuksia FI972054A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422990A GB9422990D0 (en) 1994-11-15 1994-11-15 Immunogenic compositions
PCT/GB1995/002675 WO1996014871A1 (en) 1994-11-15 1995-11-14 Immunogenic compositions

Publications (2)

Publication Number Publication Date
FI972054A FI972054A (fi) 1997-05-14
FI972054A0 true FI972054A0 (fi) 1997-05-14

Family

ID=10764393

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972054A FI972054A0 (fi) 1994-11-15 1997-05-14 Immunogeenisiä koostumuksia

Country Status (19)

Country Link
EP (1) EP0792165B1 (fi)
JP (1) JP4297515B2 (fi)
KR (1) KR970706848A (fi)
CN (1) CN100346828C (fi)
AT (1) ATE249841T1 (fi)
AU (1) AU700910B2 (fi)
CA (1) CA2205083A1 (fi)
DE (1) DE69531793T2 (fi)
DK (1) DK0792165T3 (fi)
ES (1) ES2210318T3 (fi)
FI (1) FI972054A0 (fi)
GB (1) GB9422990D0 (fi)
IL (1) IL116010A0 (fi)
MX (1) MX9703480A (fi)
NO (1) NO972219L (fi)
NZ (1) NZ295238A (fi)
PT (1) PT792165E (fi)
WO (1) WO1996014871A1 (fi)
ZA (1) ZA959729B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
AU736038C (en) * 1997-07-10 2006-08-10 Intervet Australia Pty Limited Non-aqueous vaccines
WO1999002182A2 (en) * 1997-07-10 1999-01-21 Biotech Australia Pty. Limited Non-aqueous vaccines
CN1295480A (zh) * 1998-02-12 2001-05-16 美国氰胺公司 含有白细胞介素－12和呼吸道合胞病毒抗原的疫苗
AU759391B2 (en) * 1998-02-12 2003-04-10 Wyeth Holdings Corporation Pneumococcal and meningococcal vaccines formulated with interleukin-12
ES2226338T3 (es) * 1998-02-12 2005-03-16 Wyeth Holdings Corporation Vacuna que comprenden interleucina 12 y antigeno del virus del herpes simple.
CN1306438A (zh) * 1998-05-07 2001-08-01 科里克萨有限公司 佐剂组合物及其使用方法
WO2000003724A1 (fr) * 1998-07-16 2000-01-27 Hayashi, Akira Preparations pour immunotherapie anticancereuse comprenant un constituant somatique bacterien en tant qu'ingredient actif
EP2197497B1 (en) 2007-09-27 2016-06-01 ImmunoVaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
BRPI0817484B1 (pt) * 2007-10-03 2021-08-17 Immunovaccine Technologies Inc Composição de vacina sem água, processo de produção e o uso dos mesmos
CA2723918C (en) 2008-06-05 2018-01-09 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
CN103517714A (zh) * 2010-12-23 2014-01-15 英珀特疗法有限公司 用于刚地弓形虫感染和弓形体病的诊断和治疗的方法和蛋白抗原组合物
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
CN102277373B (zh) * 2011-08-15 2014-07-02 南京大学 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用
WO2013049941A1 (en) 2011-10-06 2013-04-11 Immunovaccine Technologies Inc. Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
JP3609827B2 (ja) * 1991-06-26 2005-01-12 ヤマノウチ ユーロープ ベスローテン フェンノートシャップ 非極性基剤における小胞
AU7384994A (en) * 1993-08-06 1995-02-28 Opperbas Holding B.V. A method for high loading of vesicles with biopolymeric substances
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
EP0792165B1 (en) 2003-09-17
NZ295238A (en) 1999-01-28
NO972219D0 (no) 1997-05-14
CN1163575A (zh) 1997-10-29
ZA959729B (en) 1997-05-15
DE69531793T2 (de) 2004-07-15
PT792165E (pt) 2004-02-27
IL116010A0 (en) 1996-01-31
JP4297515B2 (ja) 2009-07-15
CN100346828C (zh) 2007-11-07
ATE249841T1 (de) 2003-10-15
GB9422990D0 (en) 1995-01-04
MX9703480A (es) 1997-08-30
NO972219L (no) 1997-07-11
CA2205083A1 (en) 1996-05-23
DK0792165T3 (da) 2004-01-05
KR970706848A (ko) 1997-12-01
AU700910B2 (en) 1999-01-14
WO1996014871A1 (en) 1996-05-23
FI972054A (fi) 1997-05-14
DE69531793D1 (de) 2003-10-23
EP0792165A1 (en) 1997-09-03
ES2210318T3 (es) 2004-07-01
JPH10508834A (ja) 1998-09-02
AU3853495A (en) 1996-06-06

Similar Documents

Publication Publication Date Title
PT792165E (pt) Composicoes imunogenicas
WO1997001640A3 (en) Vaccines against hepatitis c
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
IT8920207A0 (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
AU4622693A (en) Potentiation of immunogenic response
NO911949D0 (no) Tgf-beta-preparater.
DZ2283A1 (fr) Composition de vaccin.
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
NO894588D0 (no) Kosmetisk fremstilling som inneholder chitosan.
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
ATE377428T1 (de) Rotavirus-impfstoff
IL98262A0 (en) Chromone derivatives and pharmaceutical compositions containing them
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
NL990018I1 (nl) Vaccin tegen Pasteurella.
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
BR0009077A (pt) Antìgenos de tuberculose e métodos de uso dos mesmos
DE69431662T2 (de) Stabilisierte tablettenformulierung
AU7528087A (en) Immunogenic fraction active against bilharzioses, its preparation, and immunizing compositions containing it
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
ATE60765T1 (de) Pyranderivate.
MX9204323A (es) Procedimiento para la preparacion de derivados de taxano.
IT1294969B1 (it) Composizione immunogena per hiv
RU96116250A (ru) Штамм pestivirus, используемый для изготовления лапинизированной вирус вакцины против классической чумы свиней